1185011-75-9
1185011-75-9
Chemical Structure
Orphenadrine-d3
- CAS. Nr.: 1185011-75-9
- Formula:C18H20D3NO
- Molecular Weight:272.40
IUPAC Name: S-(allylthio)-L-cysteine
InChIKey: QVYRGXJJSLMXQH-BMSJAHLVSA-N
SMILES: [2H]C([2H])([2H])N(C)CCOC(C1=CC=CC=C1)C2=C(C=CC=C2)C
Biological Activity: Orphenadrine-d3 is the deuterium labeled Orphenadrine[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Orphenadrine-d3 | Orphenadrine-d3 is the deuterium labeled Orphenadrine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Orphenadrine | 99.71% | Orphenadrine ((±)-Orphenadrine) is a skeletal muscle relaxant and NMDA antagonist that also has antiparkinsonian, antihistamine, antitremor, antispasmodic, and analgesic effects. Orphenadrine inhibits the binding of [3H]MK-801 to the phencyclidine (PCP) binding site of the NMDA receptor. Orphenadrine is also an anticholinergic and CYP2B inducer. Orphenadrine may exert pro-tumor effects, causing CAR nuclear translocation, resulting in microsomal reactive oxygen species (ROS) production and oxidative stress. Orphenadrine also exerts neuronal protection, protecting rat cerebellar granule cells (CGC) from 3-NPA-induced death and has inhibitory potential against neurodegenerative diseases mediated by NMDA receptor overactivation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
